MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Multiple Myeloma Research and Treatments
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,397 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,397 works in the cohort · of 4,299,418page 7 of 48

Labels cover 1 of 2,397 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,397 of 2,397 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Multiple Myeloma: From Front-Line to Relapsed Therapies
Philippe Moreau, Cyrille Touzeau
2015· review· en· American Society of Clinical Oncology Educational Book· Medicine
distilled prediction:candidate · metaepi_narrow+insufficient_payloadconsensus · insufficient_payload
48
citations
affno abstractunlabeled
Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial
Katja Weisel, Meletios Α. Dimopoulos, Kevin Song, Philippe Moreau, Antonio Palumbo, Andrew R. Belch +9 more
2015· article· en· Clinical Lymphoma Myeloma & Leukemia· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrowconsensus · none
47
citations
affunlabeled
New Cancers after Autotransplantations for Multiple Myeloma
Anuj Mahindra, Girindra Raval, Paulette Mehta, Ruta Brazauskas, Mei-Jie Zhang, Xiaobo Zhong +26 more
2014· article· en· Biology of Blood and Marrow Transplantation· Medicine
distilled prediction:candidate · noneconsensus · none
46
citations
affunlabeled
Lenalidomide Plus High-Dose Dexamethasone Provides Improved Overall Survival Compared to High-Dose Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma (MM): Results of 2 Phase III Studies (MM-009, MM-010) and Subgroup Analysis of Patients with Impaired Renal Function.
Donna Weber, Michael Wang, Christine Chen, Andrew R. Belch, Edward A. Stadtmauer, Ruben Niesvisky +5 more
2006· article· en· Blood· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
46
citations
affno abstractunlabeled
Stem-cell transplantation in multiple myeloma
Jean‐Luc Harousseau, Philippe Moreau, Michel Attal, Thierry Façon, Hervé Avet‐Loiseau
2005· review· en· Best Practice & Research Clinical Haematology· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity
42
citations
← previousnext →

How this was built: Screen · Findings · About